| Lactose (India) Ltd | 137 Cr. | 109 | 247/84.3 | 31.1 | 46.7 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.63 Cr. | 1.90 | 4.33/1.90 | | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 4,905 Cr. | 450 | 479/192 | 110 | 22.8 | 0.15 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 34.1 Cr. | 46.0 | 92.2/37.2 | | 8.73 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 36.9 Cr. | 25.2 | 29.1/17.0 | 38.4 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 61.7 Cr. | 82.0 | 134/78.9 | 16.3 | 57.6 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 51,112 Cr. | 1,812 | 2,286/1,275 | 38.4 | 314 | 0.14 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 324 Cr. | 14.3 | 21.5/10.8 | 19.7 | 8.21 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.06 Cr. | 14.6 | 19.2/9.25 | 88.2 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 732 Cr. | 1,551 | 1,785/635 | 31.2 | 299 | 0.05 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 116 Cr. | 23.2 | 32.0/15.0 | 31.8 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 820 Cr. | 279 | 449/219 | 7.85 | 123 | 0.90 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 4.83 Cr. | 23.0 | 39.0/22.8 | 37.2 | 20.4 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 11.3 Cr. | 4.54 | 9.28/2.11 | 6.42 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 398 Cr. | 410 | 477/112 | 64.0 | 72.0 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,743 Cr. | 1,089 | 1,565/1,038 | 46.2 | 396 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 57.2 Cr. | 0.28 | 1.24/0.26 | 3.77 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 47.8 Cr. | 19.9 | 26.3/6.40 | 49.3 | 16.0 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 9.86 Cr. | 9.76 | 17.2/9.01 | | 22.6 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 174 Cr. | 487 | 896/443 | 9.42 | 563 | 0.31 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 70.7 Cr. | 70.7 | 76.6/26.1 | 181 | 34.1 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 14,581 Cr. | 1,395 | 2,452/1,345 | 40.8 | 173 | 0.77 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 19.0 Cr. | 41.5 | 88.7/37.6 | 41.3 | 21.6 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 18.8 Cr. | 7.52 | 7.66/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 17.4 Cr. | 116 | 154/63.0 | | 87.6 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 40.4 Cr. | 73.8 | 73.8/9.41 | 449 | 1.02 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 30.2 Cr. | 40.0 | 80.0/0.00 | 42.5 | 39.7 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.03 Cr. | 20.1 | 26.0/15.5 | | 11.2 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 10,385 Cr. | 598 | 1,028/492 | 29.5 | 72.4 | 0.20 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 87.7 Cr. | 20.3 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 12.2 Cr. | 24.0 | 43.7/17.4 | 52.9 | 18.7 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 93,348 Cr. | 2,262 | 3,055/2,115 | 56.0 | 376 | 0.04 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 262 Cr. | 454 | 524/241 | 27.4 | 119 | 0.99 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 40.4 Cr. | 28.2 | 62.6/28.2 | 36.4 | 17.7 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 65,851 Cr. | 1,124 | 1,365/994 | 19.2 | 598 | 0.36 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 114 Cr. | 184 | 303/170 | 166 | 69.0 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 860 Cr. | 85.9 | 123/74.0 | 22.2 | 32.6 | 1.75 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 41.6 Cr. | 31.9 | 50.0/21.0 | | 51.2 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 14,448 Cr. | 1,765 | 1,868/919 | 64.5 | 160 | 0.08 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.03 Cr. | 0.61 | 1.45/0.55 | 101 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 248 Cr. | 32.3 | 68.0/30.0 | 13.2 | 18.3 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 8.71 Cr. | 14.9 | 25.0/9.40 | | 2.55 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 128 Cr. | 5.45 | 6.57/2.82 | 299 | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 61,120 Cr. | 28,785 | 37,000/25,260 | 40.5 | 1,888 | 1.65 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 7,849 Cr. | 865 | 972/550 | 29.5 | 220 | 0.58 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 275 Cr. | 97.3 | 100/31.3 | 66.1 | 48.8 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 4,657 Cr. | 1,535 | 1,628/535 | | 104 | 0.07 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 21,763 Cr. | 1,338 | 1,870/1,110 | 397 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 859 Cr. | 247 | 330/154 | 20.0 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 4.24 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 596 Cr. | 446 | 568/270 | 12.8 | 420 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 3,245 Cr. | 460 | 950/455 | 26.0 | 348 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,631 Cr. | 1,153 | 1,595/991 | 23.1 | 768 | 0.87 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,21,121 Cr. | 3,580 | 3,790/2,886 | 55.9 | 224 | 0.89 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 1,066 Cr. | 116 | 317/98.0 | | 43.7 | 0.43 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,510 Cr. | 16.1 | 24.0/14.1 | 26.5 | 3.62 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 27,076 Cr. | 708 | 1,360/705 | 77.0 | 66.6 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 4,328 Cr. | 190 | 303/102 | | 5.04 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,05,860 Cr. | 1,691 | 1,910/1,547 | 35.2 | 324 | 0.95 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,528 Cr. | 565 | 886/441 | 394 | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,715 Cr. | 289 | 312/175 | 38.6 | 75.9 | 0.14 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 351 Cr. | 1,171 | 1,680/956 | 20.3 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 7,188 Cr. | 369 | 502/265 | 55.9 | 121 | 0.14 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 5,412 Cr. | 215 | 230/111 | 179 | 28.1 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 10,682 Cr. | 4,637 | 6,718/4,146 | 28.9 | 340 | 2.52 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,986 Cr. | 2,400 | 2,725/1,772 | 35.8 | 335 | 0.83 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 9,705 Cr. | 5,839 | 6,739/4,904 | 31.6 | 373 | 2.14 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 168 Cr. | 47.7 | 87.5/42.0 | | 16.8 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 23,191 Cr. | 5,075 | 5,993/3,701 | 34.3 | 922 | 0.69 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 121 Cr. | 98.7 | 348/81.0 | 8.58 | 80.4 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,540 Cr. | 415 | 582/281 | | 136 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 4,264 Cr. | 842 | 1,998/604 | 50.0 | 250 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 22,881 Cr. | 17,837 | 18,100/10,060 | 117 | 1,263 | 0.07 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 330 Cr. | 14.7 | 44.9/13.0 | | 42.6 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 14,374 Cr. | 802 | 1,505/660 | 8.47 | 425 | 0.75 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,575 Cr. | 47.0 | 91.7/41.7 | 27.8 | 21.1 | 0.43 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,292 Cr. | 183 | 359/162 | 23.7 | 54.4 | 0.44 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 100 Cr. | 63.3 | 130/62.8 | | 93.9 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 338 Cr. | 94.1 | 177/90.2 | 45.0 | 29.0 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 90,039 Cr. | 1,972 | 2,403/1,774 | 20.8 | 430 | 0.61 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,047 Cr. | 522 | 980/499 | 12.1 | 335 | 0.34 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 53,065 Cr. | 982 | 995/474 | 77.7 | 91.1 | 0.12 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 892 Cr. | 859 | 1,235/596 | 20.5 | 256 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 148 Cr. | 68.7 | 129/63.6 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 767 Cr. | 158 | 322/154 | 22.0 | 107 | 1.89 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 663 Cr. | 380 | 500/265 | 23.7 | 116 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 17,949 Cr. | 1,127 | 1,275/802 | 36.1 | 414 | 0.44 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 26,660 Cr. | 1,703 | 1,952/1,303 | 38.9 | 221 | 0.91 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,440 Cr. | 216 | 328/193 | 32.9 | 38.0 | 1.16 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 33,509 Cr. | 1,318 | 1,758/1,168 | 37.5 | 274 | 0.30 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,658 Cr. | 90.7 | 127/57.5 | 25.2 | 57.5 | 0.88 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 740 Cr. | 101 | 124/67.2 | 33.6 | 194 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 2,408 Cr. | 261 | 355/190 | | 106 | 0.08 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,867 Cr. | 232 | 465/229 | 45.3 | 102 | 0.60 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,362 Cr. | 1,602 | 2,786/1,243 | 36.2 | 369 | 0.44 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,355 Cr. | 334 | 504/285 | 54.9 | 60.0 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 13,474 Cr. | 555 | 628/412 | 28.2 | 153 | 0.27 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 51,112 Cr. | 1,812 | 2,286/1,275 | 38.4 | 314 | 0.14 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 43,888 Cr. | 2,588 | 3,516/1,921 | 46.0 | 101 | 1.62 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 30,696 Cr. | 1,863 | 2,131/1,200 | 26.5 | 610 | 0.97 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,934 Cr. | 426 | 530/359 | 30.8 | 149 | 1.17 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 21,728 Cr. | 1,594 | 1,910/1,097 | 56.1 | 210 | 0.46 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,00,617 Cr. | 1,205 | 1,406/1,020 | 17.4 | 432 | 0.66 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,907 Cr. | 249 | 322/177 | 26.1 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,21,744 Cr. | 1,506 | 1,673/1,310 | 22.4 | 408 | 0.86 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 14,695 Cr. | 1,932 | 2,641/1,551 | 25.0 | 416 | 0.31 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 313 Cr. | 106 | 203/95.6 | 154 | 33.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,352 Cr. | 128 | 191/105 | 12.3 | 99.7 | 0.39 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 64.0 Cr. | 39.2 | 72.0/37.7 | 22.9 | 11.5 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 50,885 Cr. | 380 | 406/291 | 141 | 180 | 0.13 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,686 Cr. | 1,670 | 2,215/1,430 | 37.2 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 130 Cr. | 81.9 | 141/76.3 | 18.2 | 48.6 | 1.47 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 384 Cr. | 175 | 188/67.8 | 38.1 | 35.8 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 22,706 Cr. | 9,078 | 10,691/6,220 | 107 | 308 | 0.35 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 2,040 Cr. | 708 | 843/544 | 37.4 | 113 | 0.65 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 170 Cr. | 81.2 | 137/79.7 | 6.44 | 86.4 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 67,774 Cr. | 5,668 | 5,787/4,492 | 29.8 | 1,002 | 0.79 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 18,118 Cr. | 922 | 1,124/725 | 28.6 | 271 | 1.19 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 486 Cr. | 857 | 1,540/763 | 77.3 | 688 | 0.58 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 31,541 Cr. | 2,524 | 3,116/2,022 | 32.4 | 345 | 1.11 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,468 Cr. | 310 | 498/258 | 25.3 | 127 | 1.68 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 4,516 Cr. | 491 | 575/312 | 23.7 | 146 | 0.20 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 19,611.51 Cr | 1,177.38 | | 55.93 | 198.12 | 0.34% | 16.24% | 14.95% | 6.10 |